相关实验视频
Updated: Jul 11, 2026

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
概括
法瓦豆提取物是什么意思
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 法瓦豆提取物具有凝血特性.
- 了解涉及豆血结的分子相互作用至关重要.
研究的目的:
- 为了研究特定的碳水化合物和分子大小调节法瓦豆血凝.
- 阐明碳水化合物与豆血凝素相互作用的结构要求.
主要方法:
- 使用各种糖 (d-葡萄糖,d-果糖,d-银糖,乳糖) 的血液凝结抑制试验.
- 使用高分子量和低分子量德克斯进行血凝增强试验.
- 碳水化合物的结构特征影响血液凝结的分析.
主要成果:
- D-葡萄糖,d-果糖和麦芽糖抑制了血液凝结,这表明特定基组配置的作用.
- D-银糖和乳糖没有抑制血凝,这可能是由于碳4缺少基.
- 高分子量德克斯增强了血液凝结,支持分子大小的作用.
结论:
- 碳水化合物的特定结构特征,特别是基组的位置,对于抑制法瓦豆血结合至关重要.
- 大分子尺寸,如高分子量德克斯所示,增强了法瓦豆的血凝结.
- 这些发现支持了分子大小和特定碳水化合物结构影响法瓦豆乳活性的假设.
相关概念视频
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

